Status:
RECRUITING
A Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Massachusetts Institute of Technology
Walter Reed Army Institute of Research (WRAIR)
Conditions:
Amputation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The hypothesis of this research protocol is that the investigators will be able to redesign the manner in which upper limb amputations are performed so as to enable volitional control of next generati...
Detailed Description
Upper extremity amputation is among the oldest known surgical procedures in medical history, with many of its technical principles having first been elucidated by Hippocrates. Despite the passage of m...
Eligibility Criteria
Inclusion Criteria:
- Males or females between the ages of 18 and 65
- Candidates for elective unilateral or bilateral upper extremity amputation at either the above elbow or below elbow level due to traumatic injury, congenital limb deformities or progressive arthritis
- Must demonstrate sufficiently sound health to undergo the operative procedure, including adequate cardiopulmonary stability to undergo general anesthesia (specifically, American Society of Anesthesiology Class I or II)
- Must have intact inherent wound healing capacity
- Must demonstrate adequate communication skills to convey the status of their sensorimotor recovery throughout the postoperative phase,
- Must exhibit proper level of motivation to comply with postoperative follow up requirements
- Must be willing to also consent to study activities taking place at Massachusetts Institute of Technology (approved under same IRB protocol via ceded IRB review) as some outcome measures will be assessed at that site
Exclusion Criteria:
- Patients beyond the stated age restrictions
- Those with severe illness rendering them unable to undergo the operative procedure safely (e.g., unresolved sepsis or cardiopulmonary instability manifest as documented coronary artery disease and/or chronic obstructive pulmonary disease)
- Patients with active infections, particularly deep infections in the arm to be amputated
- Patients who are taking immunosuppressive agents
- Patients with impairment in inherent wound healing pathways, such as those with primary connective tissue disorders or those on chronic steroid therapy
- Patients with extensive peripheral neuropathies (diabetic or otherwise) that would potentially inhibit appropriate reinnervation of the surgical constructs
- Active smokers; those patients willing to undergo tobacco cessation will need to be completely abstinent from tobacco use for at least 6 weeks preoperatively
- Patients who are unable to provide informed consent and those with a demonstrated history of poor compliance
- Pregnant women will not be considered due to the potential risks of general anesthesia
Patients will not be excluded from participation in the study on the grounds of minority status, religious status, race or gender. Non-English speaking patients will not be excluded from the study; interpreters will be made available to them for translation of both verbal interactions and written documents.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03882073
Start Date
May 1 2019
End Date
September 30 2026
Last Update
October 20 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed National Military Medical Center
Bethesda, Maryland, United States, 20889
2
Brigham & Women's Hospital
Boston, Massachusetts, United States, 02114
3
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
4
Massachusetts Institute of Technology Media Lab
Cambridge, Massachusetts, United States, 02139